Tempest Therapeutics Inc. buy BiotechBee
Start price
16.10.23
/
50%
€6.05
Target price
31.05.25
€12.00
Performance (%)
-81.50%
End price
08.09.24
€1.12
Summary
This prediction ended on 08.09.24 with a price of €1.12. Massive losses of -81.50% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tempest Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
According to BiotechBee what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Buy mit Kursziel 12,0